The global pharmaceutical patent system is costing lives by keeping lifesaving drugs artificially expensive. Drawing on law, economics, public health and ethics, we unpack how corporations use legal tactics to extend monopolies, the human toll in low- and high-income countries, and the policy tools that can restore access.

What we'll discuss:
- 🧾 Secondary patenting and evergreening
- 🕸️ Patent thickets and legal barriers
- 💸 Pay-for-delay and market manipulation
- 🌍 TRIPS flexibilities and compulsory licensing
- ⚖️ Policy fixes and legal reforms
- ✊ How public pressure can force change

📃 Access the full research here：
Pharmaceutical Apartheid: How Patents Kill Access

About Atypica
Atypica is an AI-powered content brand focused on global markets, technology, and consumer mechanisms. We use interdisciplinary methods to dissect overlooked structural variables, business logic, and pattern shifts that shape the future.

💻 Technical Support
Agent Support: atypica.AI
Model Support: Creative Reasoning

Start a research topic you're interested in, and it may become a future in-depth podcast episode
View all research